CLASS II Device recall · Reported 22 Apr 2020 · FDA Enforcement Report

Vacuette Tube 9NC Coagulation Sodium Citrate recalled

Greiner Bio-One North America is recalling Vacuette Tube 9NC Coagulation Sodium Citrate 3.2%, distributed nationwide in the US. The recall was initiated on 12 Mar 2020 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesItem no. 454322. Lot no. B1908355. DI no. (01)29120017574488 (17) 200809 (10)B1908355.
Quantity recalled1,000,800 units.

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1714-2020
FDA event ID
85215
Recalling firm
Greiner Bio-One North America, Monroe, NC
Classification
Class II
Status
Terminated
Recall initiated
12 Mar 2020
FDA classified
15 Apr 2020
Reported
22 Apr 2020
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

12 Mar 2020Recall initiated by company
15 Apr 2020Classified by FDA+34 days
22 Apr 2020Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Concerned lot of VACETTE 2mL 9NC Coagulation Tubes were shown to have inconsistent amounts of the 2.3% sodium citrate.

Product as listed by the FDA

VACUETTE Tube 2ml 9NC Coagulation Sodium Citrate 3.2%. Item no. 454322. Lot no. B1908355.

Where it was distributed

US nationwide distribution in the states of: NJ, IN, TN, MI, NC, WA, KS, CA, LA, IL, MD, NY, OH, TX, GA, KY, PA, CO, MA, PR, FL, AR, OK and NE.

Nationwide ArkansasCaliforniaColoradoFloridaGeorgiaIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMichiganNorth CarolinaNebraskaNew JerseyNew YorkOhioOklahomaPennsylvania

Questions about this recall

Why was it recalled?

Concerned lot of VACETTE 2mL 9NC Coagulation Tubes were shown to have inconsistent amounts of the 2.3% sodium citrate.

Which lots are affected?

Item no. 454322. Lot no. B1908355. DI no. (01)29120017574488 (17) 200809 (10)B1908355.

Where was it sold?

US nationwide distribution in the states of: NJ, IN, TN, MI, NC, WA, KS, CA, LA, IL, MD, NY, OH, TX, GA, KY, PA, CO, MA, PR, FL, AR, OK and NE.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Greiner Bio-One North America

All 16

Other Other Medical Devices recalls

All 13,778